MT-RNR2 and cancer: The present analysis suggests rational, evolution-driven bases for engineering oncolytically superior strains of F and HN glycoproteins of Newcastle disease virus for cancer therapy [50], which will be presented separately, as will an analysis of HA flu evolution.